One of our main objectives is to translate the research developed at the IN into novel therapies for nervous system diseases. To this aim, we perform research on nerve regeneration, demyelinating diseases, Parkinson disease, Alzheimer, ALS and chronic pain among others.
The TRANSLATION axis (Coordinators H Cabedo & S de Santis) seeks opportunities for collaboration and translation to the clinic. IN researchers have developed translational research lines in close collaboration with clinicians from local and national hospitals and other health institutions. The axis aims to potentiate these collaborations by the organization of meetings and the establishment of collaboration agreements between the IN and professional and patients organizations, and institutes dedicated to clinical research.
For general communications, queries and questions, please contact us at: firstname.lastname@example.org
The translational research is developed in close collaboration with clinicians from local hospitals and other health institutions:
- ISABIAL: Several groups of the IN form part of the Alicante Institute for Biomedical and Health Research (ISABIAL)
- FISABIO: The IN has also a research agreement with the Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO) a nonprofit scientific and healthcare entity, whose primary purpose is to encourage, to promote and to develop scientific and technical health and biomedical research in Valencia Region.
- CIBER and RICORS: The IN also works in close collaboration with different CIBERs and RICORs, networks dependent on the ISCIII, aimed at coordinate Spanish research on the most prevalent human diseases.
ISABIAL – Instituto de investigación Sanitaria y Biomédica de Alicante
ISABIAL is constituted as a multidisciplinary and translational biomedical research space oriented to basic, clinical, epidemiological and health services research. ISABIAL contributes to increasing the quality of research in biomedicine developed in Alicante, as a result of the association between researchers from the Hospital General, University of Alicante (UA) and University Miguel Hernández (UMH). ISABIAL was accredited as an “Instituto de Investigación Sanitaria” by the ISCIII in February 2020.